Login / Signup

Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open-label interventional study.

Avner EhrlichKonstantinos IoannidisMakram NasarIsmaeel Abu AlkianYuval DaskalNofar AtariLimor KlikerNir RainyMatan HofreeSigal Shafran TikvaInbal HouriArrigo CiceroChiara PavanelloCesare R SirtoriJordana B CohenJulio A ChirinosLisa DeutschMerav CohenAmichai GottliebAdina Bar-ChaimOren ShiboletMichal MandelboimShlomo L MaayanYaakov Nahmias
Published in: eLife (2023)
NCT04661930.
Keyphrases
  • open label
  • phase iii
  • coronavirus disease
  • phase ii
  • sars cov
  • clinical trial
  • double blind
  • phase ii study
  • study protocol
  • placebo controlled
  • squamous cell carcinoma
  • cross sectional